Finerenone was recently found to reduce the risk of clinically important kidney outcomes in #CKD patients with type 2 diabetes. Have a look at this FIDELITY trial analysis to learn more.
Click on the image to download the infographic.
ISN-ACT Global Trials Focus editorial team member Neeru Agarwal summarizes the design... read more
The ISN is pleased to welcome six dynamic young professionals to the ISN Young Nephrologists... read more
ISN-supported speaker Dr. McCafferty (far right) at the Pakistan Society of... read more
How do you build and nurture a thriving community of early-career... read more
Staff from the SPMC visit the SGH Transplant Center The ISN and... read more
Kidney International® A Toolkit for ISN’s Registry Initiative, SharE-RR This paper, led by... read more
The Latin-American Society of Nephrology and Hypertension (SLANH) has joined the... read more
Explore hundreds of hours of captivating WCN'24 content at the ISN Academy, featuring cutting-edge... read more
The 2023 ISN Global Kidney Health Atlas (GKHA) sheds light on... read more
Celebrated Belgian landmark “Manneken Pis” was dressed in a WKD outfit... read more
